Krsnaa Diagnostics Limited · NSE:KRSNAA

Krsnaa Diagnostics — Q2 FY2026-27 Earnings Presentation

18 slides from Krsnaa Diagnostics's earnings presentation, Nov 2, 2026

  1. Slide 1: Stock exchange intimation under Regulation 30

    Date: November 02, 2026 Ref. No.: KDL/SE/064/2026-27 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai- 400001 Mumbai – 4

  2. Slide 2: Q2 FY2026-27 Result Presentation

    Q2 FY2026-27 Result Presentation One of INDIA’S LARGEST Integrated Diagnostic Service Provider

  3. Slide 3: Disclaimer

    Disclaimer This presentation contains statements that are “forward-looking statements”, including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements pertaining to Krsnaa Diagnostics’ future business developments and economic performance.

  4. Slide 4: Krsnaa Diagnostics at a glance

    196 251 Mn+ 81 CT/ MRI Centres 8,400+ Tests in Patient Touch Points in 5 Years Million+ 35% Patients Served YoY Retail Revenue In Last 5 Years Growth 334 259 19 Pathology Labs States/UT Districts 75% Presence Centers Cover Rural Presence in India PAN India Areas of India One of India’s largest NABH-

  5. Slide 5: Company Evolution: Our Success & Scale Story

    Company Evolution: Our Success & Scale Story A proven trajectory of PPP leadership, nationwide expansion, and diagnostic quality excellence. 2011-13 2013-18 2021-22 2022-23 INCEPTION PPP ENTRY IPO & EXPANSION QUALITY FIRST Kick Start with 2 Radiology Centers 1st PPP Contract with 12 CT Centers in Su

  6. Slide 6: Q2 FY27 Financial Performance

    Q2 FY27 Financial Performance Particulars Q2 FY27 Q2 FY26 YoY % Particulars Q2 FY27 Q2 FY26 YoY % Revenue 2,710 2,060 32% No. of Test Performed (Mn) 30.3 16.4 85% EBIDTA 719 602 20% No. of Patient Served (Mn) 7.3 5.4 35% EBIDTA Margin 27% 29% 2% NABL Accreditation 57 57 (Pathology lab) PAT 246 239 3

  7. Slide 7: Retail Business Highlights

    Retail Business Highlights Revenue Retail Revenue Retail Revenue Patient Count Test Volume (INR Mn) (Mn) (Mn) Per Patient Contribution to (INR) Group Revenue 235 0.26 0.69 967 904 0.47 Q2 FY26 Q2 FY27 174 0.18 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 8% 9% Up 35% YoY Up 45% Yo

  8. Slide 8: Growth Drivers

    Growth Drivers 1.Rising Burden of Chronic & Non- 1.Unorganized-to-Organized Transition Communicable Diseases (NCDs) 2. Tier-2 / Tier-3 Geographical 2. Shift to Preventive & Wellness Expansion Health 3. Aging Population & Higher Life Expectancy Structural & Industry Demographic Consolidation Drivers

  9. Slide 9: Financial Performance

    DIAGNOSTICS Financial Performance

  10. Slide 10: Consolidated Financial Performance

    Consolidated Financial Performance In INR Mn Particulars Q2 FY 27 Q2 FY 26 Q1 FY 27 H1 FY 27 H1 FY 26 Amount % Amount % Amount % Amount % Amount % Revenue from operations 2,710 2,060 2,355 5,065 3,990 Expenses Cost of Material Consumed 558 21% 481 23% 502 21% 1,060 21% 955 24% Employee benefits expe

  11. Slide 11: Consolidated Financial Performance (balance sheet)

    Consolidated Financial Performance (INR In Mn) Assets Sep 30, 2026 Mar 31, 2026 Liabilities Sep 30, 2026 Mar 31, 2026 Equity Non-current assets Equity share capital 162.19 162.19 Other equity 9,994.83 9,641.69 Property, plant and equipment 8,488.28 6,516.27 Money received against share Capital work-

  12. Slide 12: Patient Experience at Its Best

    Patient Experience at Its Best

  13. Slide 13: Growth Engine- Enabling Reliable Diagnostics

    Growth Engine- Enabling Reliable Diagnostics Gargoti , Maharashtra Ahhilya Nagar , Maharashtra Varanasi , Uttar Pradesh Actual centre images © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 12

  14. Slide 14: Activities in Retail Business: Doctor Engagement

    Activities in Retail Business Doctor Engagement Activities Conferences and meetings with Doctors © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 13

  15. Slide 15: Activities in Retail Business: Independence Day Camps

    Activities in Retail Business Independence Day Camps across region © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 14

  16. Slide 16: Activities in Digital Marketing

    Activities in Digital Marketing Social Media Awareness Campaigns © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 15

  17. Slide 17: Contact Information

    Contact Information This presentation contains statements that are “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Krsnaa Diagnostics’ future business developments and economic perfor

  18. Slide 18: Krsnaa Diagnostics

    For further information please contact Krsnaa Diagnostics Sujoy Bose, Head- Secretarial, Legal and Compliance investors@krsnaa.in Contact: +91 73910 40109 https://krsnaadiagnostics.com

Krsnaa Diagnostics — Q2 FY2026-27 Earnings Presentation on 6ix